GP leaders across the country are advising practices to push back on private providers requesting input for weight-loss jab ...

The exception was SGLT2 inhibitors and GLP-1 receptor agonists ... may not have been eligible for certain medications due to contraindications or intolerances. Additionally, as with all ...

Similar to semaglutide treatments like Ozempic and Wegovy, Zepbound activates receptors of hormones secreted from the intestine (GLP-1 and GIP ... qualify and have no contraindications ...

Like Ozempic® and Wegovy®, Rybelsus® contains semaglutide as its active ingredient, which is a glucagon-like peptide-1 receptor agonist (GLP-1RA ... or cardiovascular disease). Contraindications: ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

Sharon Mann has lost nearly 30 pounds since starting on Mounjaro, a GLP-1 medication. Dr. Sanjay Gupta reports.

GLP-1 agonists like Ozempic effectively help manage obesity, but quitting the medication can lead to a resurgence in weight and related health issues. Gradual cessation is advised to avoid sudden ...

Between Novo Nordisk's (NVO) slightly disappointing results for its latest GLP-1 candidate, CagriSema, and questions that remain about Amgen's (AMGN) highly anticipated once-monthly injectable ...